Nataly
Nataly (Nataly Life S.L.) is a Barcelona-based medical device company developing the Nataly Pad, a non-electronic Class I device that detects postpartum hemorrhage in real time, targeting hospitals, clinics, and maternal healthcare professionals. The company is in clinical validation with two Barcelona hospitals and is expanding into a broader women's health platform.
- Company typePrivate
- Founded2021
- HeadquartersBarcelona, Spain
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nataly does
Nataly (Nataly Life S.L.) is a Barcelona-based medical device company founded in 2021 as a university project. The company develops the Nataly Pad, a Class I medical device designed to detect and quantify postpartum hemorrhage (PPH) in real time. The pad is non-electronic and non-invasive, absorbs up to 300mL of blood per unit, and triggers a PPH protocol at the 500mL threshold, enabling detection in under 30 seconds. The product targets healthcare institutions (hospitals, clinics), healthcare professionals (midwives, doctors, gynecologists), and patients (mothers), with a go-to-market model based on enterprise field sales to hospitals and clinics at approximately €2.3 per unit.
The company is currently in clinical validation, with partnerships established with Hospital Clínic Barcelona and Hospital del Mar. Beyond the core Nataly Pad, the company has articulated a multi-product platform vision spanning Flow (menstrual health), Care (post-abortion care), Nest (postpartum home recovery), and Balance (perimenopausal tracking), signaling intent to evolve from a single-product postpartum device into a broader women's health platform. The company has gained recognition through multiple awards in 2025, including the 2nd Best Catalan Startup at Tech Spirit Barcelona, 3rd Prize at the VII Expansión StartUp Awards, and the Santander X Spain Awards, and received ENISA Innovative Startup recognition in February 2026. The company is supported by Acció for international expansion and has signaled interest in UK and Latin American markets based on customer survey data.
Nataly firmographics
Firmographics- Name
- Nataly
- Legal name
- Nataly Life S.L.
- Website
- https://natalylife.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Nataly (Nataly Life S.L.) is a Barcelona-based medical device company developing the Nataly Pad, a non-electronic Class I device that detects postpartum hemorrhage in real time, targeting hospitals, clinics, and maternal healthcare professionals. The company is in clinical validation with two Barcelona hospitals and is expanding into a broader women's health platform.
- Ownership category
- akta.pro rank
Nataly industry classification
Industry- Product category
- Maternal Health Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables) (HLAHACAF)
- akta.pro secondary industry
- Postpartum & Newborn Care Telehealth (postpartum check-ins, newborn guidance) (HLALAHAD)
Keywords
Where Nataly is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Nataly business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Nataly Pad Device Sales: Sale of medical devices to healthcare institutions and professionals. The device is a Class I medical device designed for single or limited use during postpartum monitoring. Revenue generated through direct sales to hospitals, clinics, and potentially retail/home use scenarios.
- Multi-use-case Women's Health Devices: Expansion into additional women's health applications (Flow, Care, Nest, Balance) providing broader revenue opportunities across menstrual health, abortion care, home births, and menopause tracking markets.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Medical device unit cost |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Nataly product offering
Product offeringCore offering
Nataly develops and manufactures the Nataly Pad, a Class I medical device that absorbs and quantifies postpartum blood loss in real time during the critical first 24 hours after childbirth. The non-electronic, non-invasive pad enables early detection of postpartum hemorrhage (PPH) by visually measuring blood loss (up to 300mL per pad) and triggering clinical protocol when cumulative loss reaches 500mL. The device is sold to hospitals, clinics, midwives, and healthcare professionals for use in labor, delivery, and home birth settings.
Product overview
Nataly is a medical technology company developing a single unified product—the Nataly Pad—designed to detect and quantify postpartum hemorrhage (PPH) in real time. The Nataly Pad is a non-electronic, non-invasive Class I medical device that absorbs and measures blood loss during the critical first 24 hours after childbirth, enabling early clinical intervention. The company has also outlined future applications of its underlying quantification technology across additional women's health conditions, including menstrual blood loss (Flow), post-abortion monitoring (Care), home birth recovery (Nest), and perimenopausal tracking (Balance), though these remain prospective use cases rather than separate commercial products.
Differentiator
Problem solved
Functional benefit
Brands
- Nataly Pad: A postpartum pad that absorbs and quantifies blood in real time. Designed to detect excessive bleeding immediately and support timely clinical response for postpartum hemorrhage (PPH). Class I medical device intended for the critical first 24 hours after childbirth.
Products and services
- Nataly Pad The Nataly Pad is a Class I medical device designed to absorb and quantify postpartum blood loss in real time during the first 24 hours after childbirth. Each pad absorbs up to 300 mL of blood with visible quantification from the outside, and a PPH clinical protocol is activated when cumulative blood loss reaches 500 mL. The non-electronic, non-invasive device is intended for use by hospitals, clinics, midwives, and home birth settings to enable early detection of postpartum hemorrhage and timely clinical intervention.
Quantifiable outcome
- 42,000+ lives could be saved yearly with 90% detection accuracy
- +6 more outcomes
Companies that use Nataly
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
Nataly technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Nataly partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and supporting.
- Hospital Clínic BarcelonacoreClinical validation partner collaborating with Nataly for device testing and development. The hospital has validated both the clinical need and the technology potential for postpartum hemorrhage detection.
- Hospital del MarcoreClinical partnership for postpartum hemorrhage detection device development and validation in a hospital setting.
- StartUB!coreUniversity startup incubator providing office space and support services. Nataly is hosted at StartUB! Offices in Barcelona, representing the company's origin as a university project.
- EurecatsupportingTechnology center providing R&D support and technical expertise for biomedical device development.
- CIMTIsupportingBiomedical research institute supporting innovation in medical technologies for maternal health.
- AccciósupportingCatalonia's business development agency supporting Nataly's growth and international expansion.
- Pons IPsupportingIntellectual property consulting firm supporting patent strategy and IP protection for the Nataly device.
- IntelectiumsupportingConsulting partner providing strategic planning and business development support for scaling the company.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
Nataly competitors and assessment
Company assessmentBroad incumbents
- Stryker: Stryker is a major medical device company with surgical and OB-related products sold to hospitals globally. Although not specialized in maternal health, its scale, capital, and hospital relationships make it a plausible acquirer or competitor in the postpartum device space.
- Becton Dickinson (BD): BD is a large global medical device and diagnostics company with a portfolio spanning women's health, maternity, and surgical supplies. While not focused specifically on PPH detection, BD's scale, distribution, and hospital salesforce make it a meaningful broad incumbent competing for the same maternal-care budgets.
- Hologic: Hologic is a women's health-focused medical technology company offering diagnostics, surgical devices, and postpartum care products. Its broad women's health portfolio and established hospital channel position it as a relevant incumbent in the same clinical specialty.
- Medtronic: Medtronic is one of the world's largest medical device companies and operates a women's health business alongside broader surgical and patient monitoring portfolios. Its diversification across patient monitoring and women's health makes it a relevant broad incumbent for benchmarking.
Others
- Maven Clinic: Maven Clinic is a digital women's and family health platform offering virtual care for pregnancy, postpartum, and reproductive health. While it is a digital services company rather than a hardware device maker, it targets the same maternal-care customer and is reshaping how postpartum support is delivered.
Direct peers
- Medline Industries: Medline is one of the largest privately-held medical supply manufacturers and distributors, with an extensive OB/maternity product line including underpads, drapes, and postpartum consumables sold to hospitals and clinics. It competes with Nataly for the same postpartum supply budget line at the same hospital customers.
- CooperSurgical: CooperSurgical is the women's health and OB/GYN medical device division of Cooper Companies, offering a broad portfolio of instruments, supplies, and consumables used in labor & delivery and postpartum care. It is the most directly comparable peer given its overlap with Nataly's OB/postpartum customer base and medical-device distribution model.
Emerging players
- Laerdal Global Health: Laerdal Global Health is a Norway-based non-profit developing affordable medical devices and training solutions for maternal and newborn health in low-resource settings. Its mission, target customer, and product-development approach closely parallel Nataly's focus on accessible maternal health devices.
- Janitri Innovations: Janitri Innovations is an Indian maternal-health startup that has developed wearable fetal and maternal monitoring devices targeting low-resource hospital settings. It is comparable to Nataly as an emerging-stage medical device company addressing maternal monitoring in cost-constrained markets.
- Sera Prognostics: Sera Prognostics is a maternal health diagnostics company developing biomarker-based tests to predict pregnancy complications. It is comparable as an emerging-stage company targeting objective measurement in maternal care, though it focuses on predictive diagnostics rather than real-time postpartum monitoring.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Nataly social profiles
Digital presenceNataly financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nataly leadership team
Management profileNumber of profiles
Profiles5 records
Nataly funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nataly M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nataly
What does Nataly do?
Nataly develops and manufactures the Nataly Pad, a Class I medical device that absorbs and quantifies postpartum blood loss in real time during the critical first 24 hours after childbirth. The non-electronic, non-invasive pad enables early detection of postpartum hemorrhage (PPH) by visually measuring blood loss (up to 300mL per pad) and triggering clinical protocol when cumulative loss reaches 500mL. The device is sold to hospitals, clinics, midwives, and healthcare professionals for use in labor, delivery, and home birth settings.
Is Nataly a public or private company?
Nataly is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Nataly founded?
Nataly was founded in 2021. It employs 1 to 10 people.
Where is Nataly based?
Nataly is headquartered in Barcelona, Spain, in the Europe region.
How does Nataly make money?
Two revenue lines are on record. Nataly Pad Device Sales are the primary driver. The others are multi-use-case Women's Health Devices.
Who are Nataly's main competitors?
Broad incumbents on record are Stryker, Becton Dickinson (BD), Hologic and Medtronic. Maven Clinic is listed as an others. Direct peers are Medline Industries and CooperSurgical. Emerging players are Laerdal Global Health, Janitri Innovations and Sera Prognostics.
Does Nataly have an API?
No public API is recorded for Nataly.
What industry is Nataly in?
Nataly's product category is Maternal Health Medical Devices. Its primary akta.pro industry code is HLAHACAF, Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables), with a secondary code of HLALAHAD, Postpartum & Newborn Care Telehealth (postpartum check-ins, newborn guidance). Its NAICS code is 339113 and its SIC code is 3841.